ChaosBio is an early-stage life sciences investment platform founded by Chao Zheng, PhD, a pharmaceutical R&D operator turned investor. The firm backs seed-stage companies across therapeutics, medical devices, digital health, and life sciences infrastructure, evaluating opportunities through a structured framework that assesses scientific, development, manufacturing, execution, and financing risk. ChaosBio operates with an operator's perspective, combining scientific and development expertise with disciplined investment research. The firm invests directly and through special purpose vehicles, working with a network of life sciences investors around selected opportunities. Portfolio companies include Astrocyte Pharmaceuticals, Hilltop Bio, Sonorous, Healionics, Feel Therapeutics, Auctus Surgical, Single Pass, HexemBio, BMI OrganBank, and Pluvia Biotech.
Profile auto-generated from public sources — details unverified.